Stanley Druckenmiller's position in Verona Pharma Plc is currently worth $106M. That's 2.68% of their equity portfolio (11th largest holding). The investor owns 1.18% of the outstanding Verona Pharma Plc stock. The stake costed the investor $31.3M, netting the investor a gain of 240% so far.